Skip to main content
. 2019 Mar 18;7(3):48. doi: 10.3390/medsci7030048

Figure 5.

Figure 5

Partial response of a 69-year-old patient with dedifferentiated liposarcoma treated with pazopanib as second-line therapy. CT scans before (a) and 3 months after (b) pazopanib show significant shrinkage of the tumor that was attached to the left psoas muscle as indicated by the red arrow.